Conserved Enzymatic Peptides in Bitis arietans Venom Revealed by Comparative Proteomics: Implications for Cross-Reactive Antibody Targeting
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031431 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Kemily Stephanie de Godoi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunochemistry Laboratory, Instituto Butantan, São Paulo 05503-900, Brazil. Hauptthemen laut MEDLINE: Proteomics, Viper Venoms, Bitis, Peptides. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, GlaxoSmithKline (Brazil), FAPESP—CeTICS.
Abstract (Originalsprache)
Snakebite envenoming remains a critical public health issue, and the molecular variability of venoms limits the cross-species efficacy of conventional antivenoms. Here, we conducted a comparative proteomic analysis of Bitis arietans venom to identify conserved peptide regions derived from enzymatic toxins and evaluate their potential relevance for complementary immunotherapeutic applications. Enzyme-enriched venom fractions were isolated through sequential affinity and ion-exchange chromatography and were subsequently characterized using fluorogenic FRET substrates and inhibitor assays. LC–MS/MS analysis identified 1099 proteins and revealed 36 conserved peptides within snake venom metalloproteinases (SVMPs), serine proteases (SVSPs), and phospholipase A2 (PLA2), particularly located near catalytic residues and structurally essential motifs such as the HExxHxxGxxH zinc-binding site in SVMPs, the His-Asp-Ser catalytic triad in SVSPs, and the Ca2+-binding loop in PLA2, across Viperidae venoms. These conserved regions were also observed in homologous toxin isoforms from additional Viperidae genera, supporting the evolutionary conservation of key functional domains. While sequence conservation alone does not guarantee neutralization capacity, the identified regions represent strong candidates for structural epitope mapping and targeted antibody development. This study provides a peptide-level framework for advancing complementary antibody-based therapies designed to broaden cross-species toxin recognition, reduce antivenom dosage requirements, and improve clinical outcomes in snakebite envenoming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunochemistry Laboratory, Instituto Butantan, São Paulo 05503-900, Brazil.
- Laboratory of Structure and Function of Biomolecules, Instituto Butantan, São Paulo 05503-900, Brazil.
- Biotechnology Center, Nuclear and Energy Research Institute (IPEN), São Paulo 05508-900, Brazil.
- Centre of Excellence in New Target Discovery (CENTD), Instituto Butantan, São Paulo 05503-900, Brazil.
ORCID-Profile: Kemily Stephanie de Godoi, Fernanda Calheta Vieira Portaro, Patrick Jack Spencer, Hugo Vigerelli
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- GlaxoSmithKline (Brazil)
- FAPESP—CeTICS
- São Paulo Research Foundation
- GlaxoSmithKline Grant
Zitieren
APA
Godoi, K. S., Portaro, F. C. V., Spencer, P. J., Vigerelli, H., & Silva, W. D. D. (2026). Conserved Enzymatic Peptides in Bitis arietans Venom Revealed by Comparative Proteomics: Implications for Cross-Reactive Antibody Targeting. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031431
Vancouver
Godoi KS, Portaro FCV, Spencer PJ, Vigerelli H, Silva WDD. Conserved Enzymatic Peptides in Bitis arietans Venom Revealed by Comparative Proteomics: Implications for Cross-Reactive Antibody Targeting. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031431
BibTeX
@article{Godoi2026,
author = {Godoi, Kemily Stephanie de and Portaro, Fernanda Calheta Vieira and Spencer, Patrick Jack and Vigerelli, Hugo and Silva, Wilmar Dias da},
title = {Conserved Enzymatic Peptides in Bitis arietans Venom Revealed by Comparative Proteomics: Implications for Cross-Reactive Antibody Targeting},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031431}
}
EUVIMED